E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers 2 > Headlines for 21st Century Oncology Holdings, Inc. > News item
Published on 4/14/2015 in the Prospect News High Yield Daily.

21st Century Oncology expected to sell $400 million eight-year notes via Morgan Stanley

By Paul A. Harris

Portland, Ore., April 14 – 21st Century Oncology Holdings, Inc. is expected to come to market with a $400 million offering of eight-senior senior notes (Caa2/CCC), in a deal that will be led by Morgan Stanley & Co. LLC, according to a market source.

The Fort Meyers, Fla.-based provider of cancer treatment services is also in the market with a $570 million term loan that launched on April 14.

Proceeds will be used to refinance debt, including the 11¾ notes via a tender offer that expires on May 8, the source said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.